Company attributes
Industry
Location
B2X
Founder
Pitchbook URL
Number of Employees (Ranges)
1 – 10
Full Address
1 Columbus Square S22G New York, NY 10019 United States
Investors
DUNS Number
783142131
Total Funding Amount (USD)
1,000,000
Latest Funding Round Date
September 3, 2009
Latest Funding Type
VentriNova specializes in cardiac regenerative medicine by reversing cardiac damage pharmacologically. VentriNova’s pioneering approach of cyclin A2 modulation stimulates endogenous growth of new myocytes (heart muscle cells).
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
